AURA Stock: Aura Biosciences, Inc. Stock Price, Analysis & Insights

Get live AURA stock price $6.35, comprehensive Aura Biosciences, Inc. stock analysis, charts, news, and expert forecast. Real-time AURA stock data and investment insights.

Quick links:Financial Metrics•Earnings•Analyst Forecasts•Financials•Technicals

6.35

2.01%Today

AURA • Aura Biosciences, Inc. • NASDAQ Global Market • Healthcare

Market Cap

407.67M

Volume

635.70K

52W High

9.54

52W Low

4.73

Loading chart data...

Investment Score

Annual (latest period)

Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

View full dashboardUnlock quarterlyFaster signals · Pro+

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Headquartered in Cambridge, Massachusetts, Aura Biosciences, Inc. is a biotechnology firm established in 2009 that specializes in pioneering cancer treatments. The company leverages its proprietary virus-like drug conjugate (VDC) technology platform ...

Contact Information

Website: https://www.aurabiosciences.com
Address: 85 Bolton Street
Country: US

Investment Analysis & Business Insights

Healthcare

Biotechnology

Investment Highlights

✓ Strong presence in the Healthcare sector with established market position

✓ Lower volatility stock (Beta: 0.39) may provide portfolio stability

Important Investment Considerations

⚠All investments carry risk, including potential loss of principal for Aura Biosciences, Inc. shareholders
⚠Market volatility can significantly impact stock price, especially for smaller companies
⚠Sector-specific risks in Healthcare may affect company performance
⚠Past performance does not guarantee future results for Aura Biosciences, Inc.
⚠Investors should consider how Aura Biosciences, Inc. fits within their overall portfolio allocation
⚠Valuation metrics suggest potential, but require fundamental analysis

Market Cap

407.67M

P/E Ratio (TTM)

-3.71

Beta

0.39

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

Related Stocks

Compare AURA with peer companies:

Altimmune, Inc. (ALT)

Price: $2.66
Market cap: 234.76M

Annexon, Inc. (ANNX)

Price: $5.20
Market cap: 621.89M

DBV Technologies S.A. (DBVT)

Price: $16.03
Market cap: 383.47M

Design Therapeutics, Inc. (DSGN)

Price: $10.55
Market cap: 658.92M

enGene Holdings Inc. (ENGN)

Price: $1.67
Market cap: 85.50M

Korro Bio, Inc. (KRRO)

Price: $10.94
Market cap: 108.89M

LB Pharmaceuticals Inc Common Stock (LBRX)

Price: $29.27
Market cap: 839.37M

Quantum-Si incorporated (QSI)

Price: $0.99
Market cap: 195.27M

Rocket Pharmaceuticals, Inc. (RCKT)

Price: $2.65
Market cap: 289.36M

Solid Biosciences Inc. (SLDB)

Price: $6.57
Market cap: 511.87M

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.